Found 13 matching trials
A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder PHASE2 The purpose of this study is to evaluate the safety and efficacy of PD 0332...
Show More Location
Multiple Locations
Learn More & Join Trial
A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function. PHASE1 1. To investigate the effect of kidney function on the elimination of a sin...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time PHASE1 1. To estimate the effects of multiple doses of PD 0332334 on the eliminati...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2) PHASE3 This is a 10-week trial that evaluates the efficacy and safety of PD 033233...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD) PHASE3 This is an open-label, multi-site, 6-month study of an investigational comp...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers PHASE1 The purpose of this study is to investigate the absorption, metabolism and ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) PHASE3 This is a 10-week trial that evaluates the efficacy and safety of PD 033233...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder PHASE3 This study is a randomized, double-blind, parallel-group, multi-site, Phase...
Show More Location
Cedars-Sinai Medical Center Department of Psychiatry and Behavioral Neurosciences
Learn More & Join Trial
A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder PHASE3 This study will evaluate the efficacy and safety of PD 0332334 for the trea...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects PHASE1 The purpose of this study is to investigate if PD 0332334 affects the pharm...
Show More Location
Multiple Locations
Learn More & Join Trial